NCT04201262 2025-10-14An Efficacy and Safety Study of Ravulizumab in Adult Participants With NMOSDAlexion Pharmaceuticals, Inc.Phase 3 Completed58 enrolled 19 charts
NCT03920293 2024-05-28Safety and Efficacy Study of Ravulizumab in Adults With Generalized Myasthenia GravisAlexion Pharmaceuticals, Inc.Phase 3 Completed175 enrolled 15 charts